Hopital Foch

Suresnes, Île-de-France Region 92151

0 studies enrolling now · 3 studies all time

What they study most

ALK+ Advanced NSCLC, Anal Cancer, Anal Neoplasm, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer, Androgen-Resistant Prostatic Cancer, Carcinoma, Squamous Cell of Head and Neck, Castration-Resistant Prostatic Cancer, Head and Neck Squamous Cell Carcinoma, Hormone Refractory Prostatic Cancer, Laryngeal Squamous Cell Carcinoma, Malignant Melanoma

Studies at this site

• A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors — Completed
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors — Stopped early
• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed